Rare diseases
Investigational molecules
Locations
Continued Access Study for Patients with Severe Hemophilia A Using Efanesoctocog Alfa
BulgariaStudy on the Effects of Ficlatuzumab and Cetuximab for Adults with Recurrent or Metastatic HPV-Negative Head and Neck Cancer
BulgariaStudy on Long-Term Safety of Tolebrutinib and Teriflunomide for Patients with Multiple Sclerosis
BulgariaStudy on Lisaftoclax and Acalabrutinib for Patients with Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
BulgariaLong-Term Safety Study of ACP-204 for Adults with Alzheimer's Disease Psychosis
BulgariaStudy on the Safety of Alprazolam for Treating Long Seizures in Patients Aged 12 and Older
BulgariaStudy of MK-1084 and Pembrolizumab for First-Line Treatment in Patients with Metastatic Non-Small Cell Lung Cancer with KRAS G12C Mutation and High PD-L1 Levels
BulgariaStudy on the Effectiveness and Safety of Selinexor for Patients with Myelofibrosis and Moderate Thrombocytopenia Who Have Not Used JAK Inhibitors
BulgariaStudy on Glycopyrronium Bromide for Children Aged 6-12 with Asthma
BulgariaStudy on Balcinrenone and Dapagliflozin for Patients with Heart Failure and Kidney Problems
BulgariaStudy on the Effectiveness of Concizumab for Children Under 12 with Hemophilia A or B, With or Without Inhibitors
BulgariaStudy on THIO and Cemiplimab for Patients with Advanced Non-Small Cell Lung Cancer
BulgariaTell us about your condition – we search every trial in Europe and connect you with the right site.
